Metabolic bone disease: something more than medication
Villamil Cajoto, I.; Villacián Vicedo, M.J.; Martínez Rey, C.
Revista Clinica Espanola 206(9): 465-6; author reply 466-7
2006
ISSN/ISBN: 0014-2565 PMID: 17042996 Document Number: 600305
Document emailed within 1 workday
Related Documents
Kajiwara, M.; Yajima, N.; Yamato, H. 2011: Morphological analysis of bone dynamics and metabolic bone disease. Bone histomorphometry for laboratory animals Clinical Calcium 21(4): 534-540Mori, S. 2011: Morphological analysis of bone dynamics and metabolic bone disease. Pathophisiology of Microdamage Clinical Calcium 21(4): 559-565
Yoshikawa, S. 1986: Etiology and pathology of metabolic bone diseases: Paget's disease of bone and osteosclerosis Nihon Rinsho. Japanese Journal of Clinical Medicine 44(11): 2437-2442
Peng, F.; Fu, R.; Liu, H.; Wang, Y.; Ding, K.; Ding, S.; Liu, Z.; Ruan, E.; Qu, W.; Wang, H.; Xing, L.; Wang, X.; Wang, G.; Song, J.; Wu, Y.; Li, L.; Liu, H.; Guan, J.; Shao, Z. 2015: Clinical significance of serum bone metabolic markers in diagnosis and monitoring of myeloma bone disease Zhonghua Yi Xue Za Zhi 95(42): 3436-3439
Cundy, T. 1986: Latest news on metabolic bone disease Practitioner 230(1419): 819-820
Reynolds, W.A.; Karo, J.J. 1972: Radiologic diagnosis of metabolic bone disease Orthopedic Clinics of North America 3(3): 521-543
Epstein, S. 1974: Metabolic bone disease--recent developments South African Medical Journal 48(9): 350-352
Robinson, W. 1976: New metabolic bone disease research unit Nursing Mirror and Midwives Journal 143(16): 46-49
Mankin, H.J.; Mankin, C.J. 2008: Metabolic bone disease: a review and update Instructional Course Lectures 57: 575-593
Kanabe, S. 1986: Metabolic bone disease: calcification and matrix vesicle Nihon Rinsho. Japanese Journal of Clinical Medicine 44(11): 2354-2358
Armstrong, A.; Cunningham, J. 1994: The treatment of metabolic bone disease in patients on peritoneal dialysis Kidney International. Suppl 48: S51-S57
Stanitski, D.F. 1994: Treatment of deformity secondary to metabolic bone disease with the Ilizarov technique Clinical Orthopaedics and Related Research 301: 38-41
Solt, D.B. 1991: The pathogenesis, oral manifestations, and implications for dentistry of metabolic bone disease Current Opinion in Dentistry 1(6): 783-791
Kamboj, M.K. 2007: Metabolic bone disease in adolescents: recognition, evaluation, treatment, and prevention Adolescent Medicine: State of the Art Reviews 18(1): 24-46 Viii
Maldague, B.; Malghem, J. 1982: Intracortical bone resorption: its diagnostic value in metabolic bone diseases associated with high bone-turnover Annales de Radiologie 25(5): 333-336
Caudarella, R.; Vescini, F.; Buffa, A.; Sinicropi, G.; Rizzoli, E.; La Manna, G.; Stefoni, S. 2003: Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors Journal of Nephrology 16(2): 260-266
Takami, M.; Shimada, H. 2010: Effects of SERMs on bone health. SERM and metabolic markers of bone Clinical Calcium 20(3): 365-371
Takeuchi, Y. 2007: Assessment of bone quality with metabolic bone markers Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 9): 214-218
Takahashi, S. 2013: Bone metabolic markers for evaluation of bone metastases Clinical Calcium 23(3): 391-400
Kwan Tat, S.; Pelletier, J.-P.; Lajeunesse, D.; Fahmi, H.; Lavigne, M.; Martel-Pelletier, J. 2008: The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells Clinical and Experimental Rheumatology 26(2): 295-304